Compositions and methods for the treatment of tumor of hematopoietic origin

Details for Australian Patent Application No. 2012211366 (hide)

Owner Genentech, Inc.

Inventors Chang, Wesley; De Sauvage, Frederic; Eaton, Dan L.; Ebens Jr., Allen J.; Frantz, Gretchen; Hongo, Jo-Anne S.; Koeppen, Hartmut; Polson, Andrew; Smith, Victoria

Agent Griffith Hack

Pub. Number AU-A-2012211366

Parent 2009202783

Filing date 2 August 2012

Wipo publication date 23 August 2012

International Classifications

C07K 14/705 Peptides having more than 20 amino acids

A61K 47/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 16/30 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

23 August 2012 Application Open to Public Inspection

  Published as AU-A-2012211366

23 August 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012211367-Rear portion structure of saddle-type vehicle

2012211365-Biological specimen collection and transport system and methods of use